KINISAJPMorgan_JPM25_SlidesforUpload_10.13.25_1030am

AnnaLiving with Recurrent PericarditisWe’re relentless and focused on putting patients at the center of everything we do as we strive to develop life-changing medicinesWho We AreJP Morgan ConferenceJANUARY 20252This presentation (together with any other statements or information that we may make in connection herewith) contains forward-looking statements with respect to Kiniksa Pharmaceuticals International, plc (and its consolidated subsidiaries, collectively, unless context otherwise requires, “Kiniksa,” “we,” “us” or “our”). In some cases, you can identify forward looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “goal,” “design,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential,” “strategy,” or “continue” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these identifying words. All statements contained in this presentation tha